thiophenes has been researched along with Metabolic Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Han, M; Lian, J; Su, Y | 1 |
| Miyamoto, L | 1 |
| Ha, J; Kim, J; Shin, J | 1 |
| Muqit, M; Sammler, EM; Stuart, A; Swingler, RJ | 1 |
| Schneider, P | 1 |
2 review(s) available for thiophenes and Metabolic Diseases
| Article | Year |
|---|---|
[AMPK as a Metabolic Intersection between Diet and Physical Exercise].
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Biphenyl Compounds; Diet; Drug Discovery; Eating; Exercise; Exercise Therapy; Humans; Hypoglycemic Agents; Isoenzymes; Metabolic Diseases; Metformin; Molecular Targeted Therapy; Muscle Contraction; Pyrones; Ribonucleosides; Thiophenes | 2018 |
Screening methods for AMP-activated protein kinase modulators: a patent review.
Topics: AMP-Activated Protein Kinases; Animals; Biphenyl Compounds; Drug Design; Homeostasis; Humans; Metabolic Diseases; Molecular Targeted Therapy; Neoplasms; Patents as Topic; Pyrones; Thiophenes | 2015 |
3 other study(ies) available for thiophenes and Metabolic Diseases
| Article | Year |
|---|---|
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Female; Liver; Metabolic Diseases; Muscarinic Agonists; Olanzapine; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Signal Transduction; Thiophenes; Weight Gain | 2022 |
Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations.
Topics: Adult; Dopamine; Dopamine Agonists; Humans; Male; Metabolic Diseases; Mutation; Parkinsonian Disorders; Tetrahydronaphthalenes; Thiophenes; Ubiquitin-Protein Ligases | 2009 |
Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes.
Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Dogs; Female; Fibrinolytic Agents; Imidazoles; Indenes; Kidney; Liver; Lysosomes; Male; Metabolic Diseases; Microscopy, Electron; Muscles; Propanolamines; Quinazolinones; Rats; Thiophenes | 1992 |